Some studies support that reduced TTR levels negatively correlate with disease progression [46,87,90,91]; patients with mild cognitive impairment, which often precedes AD, tend to have higher serum TTR levels, which reduce as the disease progresses [62]. The gene discussed is TTR; the disease is Cognitive impairment.